Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

National Cancer Institute (NCI) · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
allogeneic hematopoietic stem cell transplant recipient, myeloproliferative neoplasm, recurrent acute lymphoblastic leukemia, recurrent acute myeloid leukemia, recurrent chronic lymphocytic leukemia, recurrent chronic myelogenous leukemia, bcr-abl1 positive, recurrent hematologic malignancy, recurrent hodgkin lymphoma, recurrent myelodysplastic syndrome, recurrent non-hodgkin lymphoma, recurrent plasma cell myeloma, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876044
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.